BackOrganogenesis Holdings Overview

Organogenesis Holdings Current Cash

Latest current cash for ORGO: $91M.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$91.38M
16.90% YoYΔ $-18.59M vs prior year quarter

Peer average

Loading

Organogenesis Holdings Current Cash History

Loading

Organogenesis Holdings vs. peers: Current Cash Comparison

Loading

Organogenesis Holdings Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Organogenesis Holdings (ORGO) FAQ

As of the most recent data (March 2026), ORGO shows a current cash of $91M. That compares with $110M in the prior-year period — down 16.9% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, ORGO's current cash is now $91M (was $110M) — a 16.9% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Organogenesis Holdings is outperforming or lagging.

Tracking ORGO's current cash over time shows whether Organogenesis Holdings is scaling, shrinking, or reshaping that part of the business. The current reading is $91M That compares with $110M in the prior-year period — down 16.9% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current cash page, Stockcircle has Organogenesis Holdings's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current cash (currently $91M) with ownership activity and broader fundamentals.

Organogenesis Holdings's current cash is $91M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.